The Future Use of Complement Inhibitors for the Treatment of Neurological Diseases

By McGeer E.G.   McGeer P.L.  

Drugs, Vol. 55, Iss. 6, 1998-06 ,pp. : 739-746

Adis International

Access to resources Recommend Favorite

Editorial [Hot Topic: Cyclooxygenases and Cyclooxygenase Inhibitors in Neurological and Psychiatric Diseases (Executive Editor: Luisa Minghetti) ]

By  

Current Pharmaceutical Design, Vol. 14, Iss. 14, 2008-05 ,pp. : 1400-1400

Bentham Science Publishers

Access to resources Recommend Favorite

Mitochondrial Biology and Neurological Diseases

By  

Current Neuropharmacology, Vol. 14, Iss. 2, 2016-02 ,pp. : 143-154

Bentham Science Publishers

Access to resources Recommend Favorite

Polyunsaturated Fatty Acids and Neurological Diseases

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 11, 2006-11 ,pp. : 1201-1211

Bentham Science Publishers

Access to resources Recommend Favorite

TRPC Channels and their Implications for Neurological Diseases

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 1, 2010-03 ,pp. : 94-104

Bentham Science Publishers

Access to resources Recommend Favorite